Ultra‐Fine 3D Bioprinting of Dynamic Hyaluronic Acid Hydrogel for in Vitro Modeling
Advanced Materials · 2025
DOI: 10.1002/adma.202500315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Shima Tavakoli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Translational Chemical Biology Group, Division of Macromolecular Chemistry, Department of Chemistry-Ångstrom Laboratory, Uppsala University, Uppsala,…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Bioprinting, Printing, Three-Dimensional, Hydrogels. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union's Horizon 2020 Marie Sklodowska-Curie H2020-MSCA-ITN-ETN-2020, Swedish Strategic Research "StemTherapy".
Abstract (Originalsprache)
3D bioprinting bridges tissue engineering and additive manufacturing, however developing bioinks with balanced biological and physical properties remains a challenge. Hyaluronic acid (HA) is a promising base material due to its biocompatibility and cell‐recognition features. An HA‐based bioink is designed using dynamic disulfide‐crosslinking at physiological pH by modifying HA with cysteine moieties. To overcome the slow gelation kinetics typical of disulfide‐crosslinked hydrogels, potassium iodide (KI) is introduced, accelerating gelation in a concentration‐dependent manner. KI not only enhances gelation but also provides radical scavenging properties while maintaining hydrogel integrity. A low KI concentration (50 m m ) offers more than a 3 h printing window, ensures cell viability, and facilitates the use of fine needles (32G, 108 µm inner diameter). This enables the fabrication of large (>3 cm) and complex 3D structures. Using this bioink, an osteoarthritis disease model is developed to investigate interactions between human mesenchymal stromal cells (hMSCs) and chondrocytes, demonstrating the immunomodulatory effect of hMSCs on inflammation‐induced chondrocytes. Overall, the HA‐based bioink addresses critical challenges in 3D bioprinting, providing a robust platform for constructing innovative in vitro models and supporting advancements in disease modeling and precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Chemical Biology Group, Division of Macromolecular Chemistry, Department of Chemistry-Ångstrom Laboratory, Uppsala University, Uppsala, SE75121, Sweden.
- Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, 00790, Finland.
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, CF10 3NB, UK.
ORCID-Profile: Shima Tavakoli, Oommen P Oommen, Oommen P Varghese
Förderung
- European Union's Horizon 2020 Marie Sklodowska-Curie H2020-MSCA-ITN-ETN-2020
- Swedish Strategic Research "StemTherapy"
Zitieren
APA
Tavakoli, S., Kocatürkmen, A., Oommen, O. P., & Varghese, O. P. (2025). Ultra‐Fine 3D Bioprinting of Dynamic Hyaluronic Acid Hydrogel for in Vitro Modeling. Advanced Materials. https://doi.org/10.1002/adma.202500315
Vancouver
Tavakoli S, Kocatürkmen A, Oommen OP, Varghese OP. Ultra‐Fine 3D Bioprinting of Dynamic Hyaluronic Acid Hydrogel for in Vitro Modeling. Advanced Materials. 2025. doi:10.1002/adma.202500315
BibTeX
@article{Tavakoli2025,
author = {Tavakoli, Shima and Kocatürkmen, Aybike and Oommen, Oommen P and Varghese, Oommen P},
title = {Ultra‐Fine 3D Bioprinting of Dynamic Hyaluronic Acid Hydrogel for in Vitro Modeling},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202500315}
}
EUVIMED